↓ Skip to main content

Dove Medical Press

Article Metrics

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
23 Mendeley
Title
Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2013
DOI 10.2147/dmso.s51795
Pubmed ID
Authors

David Scott

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 22%
Student > Master 5 22%
Other 4 17%
Professor 2 9%
Librarian 1 4%
Other 4 17%
Unknown 2 9%
Readers by discipline Count As %
Medicine and Dentistry 8 35%
Nursing and Health Professions 4 17%
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Psychology 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 1 4%
Unknown 5 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2017.
All research outputs
#5,880,401
of 11,511,689 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#112
of 251 outputs
Outputs of similar age
#99,556
of 262,278 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#4
of 9 outputs
Altmetric has tracked 11,511,689 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 251 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,278 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.